Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4501
Global X Funds Global X HealthTech ETF
HEAL
$34.8M
| $50.8K | ﹤0.01% |
1,721
| – | – |
2023 Q2
13 quarters
|
|
4502
Future Fuel
FF
$233M
| $50.6K | ﹤0.01% |
9,893
+5,770
| +140% | +$29.7K |
2016 Q3
40 quarters
|
|
4503
Neumora Therapeutics
NMRA
$94.6M
| $50.5K | ﹤0.01% |
84,730
+18,504
| +28% | +$25.6K |
2023 Q4
11 quarters
|
|
4504
Motorcar Parts of America
MPAA
$199M
| $50.5K | ﹤0.01% |
4,811
+3,223
| +203% | +$40.2K |
2024 Q3
8 quarters
|
|
4505
Hain Celestial
HAIN
$13.6M
| $50.2K | ﹤0.01% |
102,952
+31,265
| +44% | +$18.6K |
2013 Q2
53 quarters
|
|
4506
ImageneBio Inc
IMA
$46.7M
| $49.4K | ﹤0.01% |
10,797
| – | – |
2022 Q1
18 quarters
|
|
4507
KORU Medical Systems
KRMD
$143M
| $49.1K | ﹤0.01% |
16,754
+10,191
| +155% | +$36.8K |
2023 Q4
11 quarters
|
|
4508
RideNow Group
RDNW
$212M
| $49K | ﹤0.01% |
8,911
+5,564
| +166% | +$33.8K |
2025 Q4
3 quarters
|
|
4509
DeFi Development Corp
DFDV
$109M
| $48.9K | ﹤0.01% |
+9,109
| New | +$36.4K |
2026 Q3
0 quarters
|
|
4510
Minerva Neurosciences
NERV
$116M
| $48.6K | ﹤0.01% |
14,519
+7,693
| +113% | +$33K |
2026 Q1
2 quarters
|
|
4511
ProFrac Holding
ACDC
$546M
| $48.6K | ﹤0.01% |
11,207
-107,181
| -91% | -$514K |
2022 Q3
16 quarters
|
|
4512
Atrium Therapeutics
RNA
$143M
| $48.6K | ﹤0.01% |
5,856
+3,157
| +117% | +$37.2K |
2026 Q1
2 quarters
|
|
4513
Innovator Equity Defined Protection ETF - 2 Yr to April 2027
TAPR
$10.7M
| $48.6K | ﹤0.01% |
1,810
| – | – |
2026 Q2
1 quarter
|
|
4514
iShares MSCI Israel ETF
EIS
$808M
| $48.5K | ﹤0.01% |
400
| – | – |
2026 Q2
1 quarter
|
|
4515
Innovator Equity Defined Protection ETF - 1 Yr July
ZJUL
$191M
| $48.5K | ﹤0.01% |
1,603
| – | – |
2026 Q2
1 quarter
|
|
4516
James River Group Holdings
JRVR
$180M
| $48.1K | ﹤0.01% |
14,037
+9,064
| +182% | +$38.2K |
2016 Q3
40 quarters
|
|
4517
AllianceBernstein
AB
$3.13B
| $48.1K | ﹤0.01% |
1,379
+1,235
| +858% | +$45.3K |
2025 Q4
3 quarters
|
|
4518
PrimeEnergy Resources
PNRG
$294M
| $48K | ﹤0.01% |
243
+112
| +85% | +$22.2K |
2023 Q2
13 quarters
|
|
4519
WisdomTree US Quality Growth Fund
QGRW
$3.03B
| $47.7K | ﹤0.01% |
694
| – | – |
2026 Q2
1 quarter
|
|
4520
Innovator US Equity Ultra Buffer ETF April
UAPR
$157M
| $47.6K | ﹤0.01% |
1,325
| – | – |
2024 Q4
7 quarters
|
|
4521
abrdn Physical Platinum Shares ETF
PPLT
$1.8B
| $47.3K | ﹤0.01% |
3,070
| – | – |
2023 Q1
14 quarters
|
|
4522
PUT
Xerox Holdings Corp Warrants
XRXDW
$11.6M
| $47.2K | ﹤0.01% |
171,250
| – | – |
2026 Q1
2 quarters
|
|
4523
First Northwest Bancorp
FNWB
$94.4M
| $47.1K | ﹤0.01% |
4,707
+1,159
| +33% | +$12.8K |
2016 Q3
40 quarters
|
|
4524
Alta Equipment Group
ALTG
$194M
| $46.9K | ﹤0.01% |
7,710
+4,481
| +139% | +$28.6K |
2022 Q1
18 quarters
|
|
4525
Douglas Elliman
DOUG
$142M
| $46.5K | ﹤0.01% |
30,593
+19,936
| +187% | +$35.8K |
2022 Q1
18 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.